Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Adiels

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
JCI Insight|November 10, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Plos One|July 23, 2014
Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementationDaniël B van Schalkwijk, Wilrike J Pasman, Henk F J Hendriks, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Multi-molecular scores map process-specific polygenic diabetes risk to atherosclerosis, cardiometabolic diseases, and vascular complicationsHui Li, Jakub Morze, Martin Adiels, et al.
Journal of Internal Medicine|August 19, 2021
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
BMC Public Health|June 3, 2026
Country-specific differences in the association between obesity risk factors in two high-income countries: a cross-sectional analysis from the Prospective Urban Rural Epidemiology (PURE) studyChristina E Lundberg, Martin Adiels, Victoria Miller, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2016
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal ObesityBruno Vergès, Martin Adiels, Jan Boren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 DiabetesMarja-Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
European Journal of Endocrinology|May 6, 2022
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolismMarja-Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Journal of Hepatology|August 11, 2012
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroCarlo Pirazzi, Martin Adiels, Maria Antonella Burza, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2012
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individualsMaria Antonella Burza, Carlo Pirazzi, Cristina Maglio, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
JCI Insight|November 10, 2020
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
Plos One|July 23, 2014
Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementationDaniël B van Schalkwijk, Wilrike J Pasman, Henk F J Hendriks, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Multi-molecular scores map process-specific polygenic diabetes risk to atherosclerosis, cardiometabolic diseases, and vascular complicationsHui Li, Jakub Morze, Martin Adiels, et al.
Journal of Internal Medicine|August 19, 2021
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humansJan Borén, Martin Adiels, Elias Björnson, et al.
BMC Public Health|June 3, 2026
Country-specific differences in the association between obesity risk factors in two high-income countries: a cross-sectional analysis from the Prospective Urban Rural Epidemiology (PURE) studyChristina E Lundberg, Martin Adiels, Victoria Miller, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2016
ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal ObesityBruno Vergès, Martin Adiels, Jan Boren, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 28, 2020
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 DiabetesMarja-Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
European Journal of Endocrinology|May 6, 2022
Role of endogenous incretins in the regulation of postprandial lipoprotein metabolismMarja-Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Journal of Hepatology|August 11, 2012
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitroCarlo Pirazzi, Martin Adiels, Maria Antonella Burza, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 19, 2012
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individualsMaria Antonella Burza, Carlo Pirazzi, Cristina Maglio, et al.
Pageof 13